Primary Prevention for Intermediate Risk: The More Things Change, the More They Stay the Same

Overview

Journal JACC Adv

Specialty Cardiology & Vascular Diseases

Date 2024 Jun 28

PMID 38939677

Authors

Philip Greenland

Peter A Glynn

Affiliations

Soon will be listed here.

References

Schroff P, Gamboa C, Durant R, Oikeh A, Richman J, Safford M . Vulnerabilities to Health Disparities and Statin Use in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study. J Am Heart Assoc. 2017; 6(9). PMC: 5634251. DOI: 10.1161/JAHA.116.005449. View

Mangione C, Barry M, Nicholson W, Cabana M, Chelmow D, Coker T . Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2022; 328(8):746-753. DOI: 10.1001/jama.2022.13044. View

Vega G, Wang J, Grundy S . Prevalence and significance of risk enhancing biomarkers in the United States population at intermediate risk for atherosclerotic disease. J Clin Lipidol. 2021; 16(1):66-74. DOI: 10.1016/j.jacl.2021.11.009. View

Bild D, Bluemke D, Burke G, Detrano R, Diez Roux A, Folsom A . Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol. 2002; 156(9):871-81. DOI: 10.1093/aje/kwf113. View

Blaha M, Cainzos-Achirica M, Greenland P, McEvoy J, Blankstein R, Budoff M . Role of Coronary Artery Calcium Score of Zero and Other Negative Risk Markers for Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2016; 133(9):849-58. PMC: 4775391. DOI: 10.1161/CIRCULATIONAHA.115.018524. View

Pearson G, Thanassoulis G, Anderson T, Barry A, Couture P, Dayan N . 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults. Can J Cardiol. 2021; 37(8):1129-1150. DOI: 10.1016/j.cjca.2021.03.016. View

Arnett D, Blumenthal R, Albert M, Buroker A, Goldberger Z, Hahn E . 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019; 74(10):e177-e232. PMC: 7685565. DOI: 10.1016/j.jacc.2019.03.010. View

Hong J, Blankstein R, Shaw L, Padula W, Arrieta A, Fialkow J . Implications of Coronary Artery Calcium Testing for Treatment Decisions Among Statin Candidates According to the ACC/AHA Cholesterol Management Guidelines: A Cost-Effectiveness Analysis. JACC Cardiovasc Imaging. 2017; 10(8):938-952. DOI: 10.1016/j.jcmg.2017.04.014. View

Saeed A, Zhu J, Thoma F, Marroquin O, Aiyer A, Agarwala A . Cardiovascular Disease Risk-Based Statin Utilization and Associated Outcomes in a Primary Prevention Cohort: Insights From a Large Health Care Network. Circ Cardiovasc Qual Outcomes. 2021; 14(9):e007485. DOI: 10.1161/CIRCOUTCOMES.120.007485. View

10.

Hammond M, Cameron N, Ning H, Bah I, Beltrame K, Khan S . Statin Use and Eligibility for Primary Prevention of Atherosclerotic Cardiovascular Disease Among Adults at Borderline or Intermediate Risk in the United States. J Am Heart Assoc. 2023; 12(8):e029263. PMC: 10227278. DOI: 10.1161/JAHA.122.029263. View

11.

Polonsky T, McClelland R, Jorgensen N, Bild D, Burke G, Guerci A . Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA. 2010; 303(16):1610-6. PMC: 3033741. DOI: 10.1001/jama.2010.461. View